# Urinary Microbiome as a Biomarker for Melanoma Diagnosis and Response Prediction to Systemic Tumour Therapy

> **NCT07635732** · — · RECRUITING · sponsor: **Medical University of Graz** · enrollment: 50 (estimated)

## Conditions studied

- Melanoma Stage IV

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07635732
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-08
- **Primary completion:** 2028-05
- **Final completion:** 2030-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07635732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07635732, "Urinary Microbiome as a Biomarker for Melanoma Diagnosis and Response Prediction to Systemic Tumour Therapy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07635732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*